Combining a complete platform refresh of the core implants and instruments with a full suite of enabling solutions, the Infinity™ Occipitocervial-Upper Thoracic System was designed to bring procedural efficiency to all your posterior cervical fusions.
Enabling Technology Products: Please refer to product indication manual/package insert for instructions, warnings, precautions, and contraindications.
The INFINITY™ OCT System is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7), and the thoracic spine from T1-T3:
The INFINITY™ OCT System is also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.
In order to achieve additional levels of fixation, the INFINITY™ OCT System may be connected to the CD HORIZON™ Spinal System and VERTEX™ Reconstruction System rods with the INFINITY™ OCT System rod connectors. Transition rods with differing diameters may also be used to connect the INFINITY™ OCT System to the CD HORIZON™ Spinal System. Refer to the CD HORIZON™ Spinal System package insert and VERTEX™ Reconstruction System package insert for a list of the indications of use.
Note: The 3.0mm multi axial screw (MAS) requires the use of MAS CROSSLINK™ at each level in which the 3.0mm screw is intended to be used.
The lateral offset connectors and MAS extension connectors are intended to be used with 3.5mm and larger diameter multi axial screws. The lateral offset connectors and MAS extension connectors are not intended to be used with 3.0mm screws.
Along with the benefits of this technology, there are also potential risks. Risks associated with the INFINITY™ OCT System include, but are not limited to:
Magnifuse Bone Graft
Magnifuse Bone Graft is intended for use as a bone graft substitute in bony voids or gaps of the skeletal system (i.e., spine, pelvis, and extremities) not intrinsic to the stability of the bony structure. The voids or gaps may be surgically created defects or defects created by traumatic injury to the bone.
Magnifuse Bone Graft may be used in a manner comparable to autogenous bone or allograft bone.
Magnifuse II Bone Graft
Magnifuse II Bone Graft is intended for use as a bone graft substitute in bony voids or gaps of the skeletal system (i.e., the posterolateral spine and pelvis) not intrinsic to the stability of the bony structure. The voids or gaps may be surgically created defects or defects created by traumatic injury to the bone. Magnifuse II DBM is resorbed/ remodeled and replaced by host bone during the healing process.
The following are contraindications for the use of Magnifuse™ DBM Bone Graft and Magnifuse™ II Bone Graft:
This product may contain trace amounts of antibiotics (gentamicin), surfactant, and other solutions used in processing the bone tissue as well as the PGA mesh. Caution should be exercised if the patient is allergic to these antibiotics or chemicals.
For more details see Indications, Safety, and Warnings.
As compared to Vertex Select™ Reconstruction System